DCM
HRMY icon

Davis Capital Management’s Harmony Biosciences HRMY Stock Holding History

Davis Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73 Buy
+2
New +$63 ﹤0.01% 1139

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
SCM
Sidoxia Capital Management Newport Beach, California $136M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Davis Capital Management's HRMY Position: Q2 2026 in Review

Davis Capital Management opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 2 shares worth $73. The stake represents ﹤0.01% of the portfolio and ranks #1139 among its holdings.

51 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Davis Capital Management held 2 shares of Harmony Biosciences worth $73 as of Q2 2026.
  • Harmony Biosciences was a new Davis Capital Management position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1139 holding.
  • 51 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.